, Volume 160, Issue 1, pp 9–14 | Cite as

DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples

  • Yolanda Morera-López
  • Josep Maria Torres-Rodríguez
  • Teresa Jiménez-Cabello
  • Teresa Baró-Tomás
  • Concepción Alía-Aponte
  • Marcia S. Lázera


Cryptococcus neoformans var. grubii (serotype A) was isolated from 12 soil samples mixed with pigeon droppings (16.9%) from 71 soil samples in Barcelona and rural areas of Catalonia. C. neoformans was not isolated from indoor dust and Eucalyptus debris. PCR fingerprinting was performed in 22 representative isolates and all of them corresponded to the VNI pattern. Susceptibility testing for the 22 isolates of C. neoformans var. grubii showed that all of them were susceptible to amphotericin B. Three isolates presented MICs (Minimal Inhibitory Concentrations) ≥ 1 μg/ml to Itraconazole, five MICs  ≥ 1 μg/ml to ketoconazole and four were fluconazole resistant, (MICs  ≥ 64 μg/ml), while three of them were shown to have MICs  ≥ 1 μg/ml to voriconazole. In spite that all isolates presented the same DNA fingerprinting pattern, the susceptibility to antifungals is very variable. The possibility of acquiring cryptococcosis infection with primarily resistant environment strains is feasible.


Barcelona Cryptococcus neoformans environmental isolates in vitro susceptibility PCR fingerprinting triazoles Barcelona 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1.  1.
    Franzot, SP, Salkin, IF,, Casadevall, A 1999Cryptococcus neoformans var. grubii: Separate varietal status for Cryptococcus neoformans serotype A isolatesJ Clin Microbiol37838840PubMedGoogle Scholar
  2.  2.
    Kwon-Chung, KJ, Boekhout, T, Fell, JW, Diaz, M 2002Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremenomycetidae)Taxon51804806Google Scholar
  3.  3.
    Sorrell, TC 2001Cryptococcus neoformans variety gattiiMed Mycol39155168PubMedGoogle Scholar
  4.  4.
    Baró, T, Torres-Rodríguez, JM, Hermoso Mendoza, M, Morera, Y,, Alía, C 1998First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in SpainJ Clin Microbiol36458461PubMedGoogle Scholar
  5.  5.
    Lazera, MS, Wanke, B,, Nishikwa, MN 1993Isolation of both varieties of Cryptococcus neoformans from saprophytic sources in the city of Rio de Janeiro, BrazilJ Med Vet Mycol31449454Google Scholar
  6.  6.
    Alonso, M, García, F, Mallolas, J, Soriano, A, Ortega, M, Miró, JM, Gatell, JM,, Soriano, E 1999Criptococcosis diseminada en pacientes con SIDA. Factores pronósticos de mala evoluciónMed Clin (Barc)112401405Google Scholar
  7.  7.
    Meyer, W, Castañeda, A, Jackson, S, Huynh, M,, Castañeda, E 2003the IberoAmerican Cryptococcal Study Group Molecular typing of IberoAmerican Cryptococcus neoformans isolatesEmerg Infect Dis9189195PubMedGoogle Scholar
  8.  8.
    Franzot, SP,, Hamdan, JS 1996In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugsAntimicrob Agents Chemother40822824PubMedGoogle Scholar
  9.  9.
    Mondon, P, Petter, R, Amalfitano, G, Luzzati, R, Concia, E, Polacheck, I,, Kwong-Chung, KJ 1999Heteroresistance to Fluconazole and Voriconazole in Cryptococcus neoformansAntimicrob Agents Chemother4318561861PubMedGoogle Scholar
  10. 10.
    Staib, F, Seibold, M, Artweiler, E, Frohlich, B, Weber, S,, Blisse, A 1987The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of Cryptococcus neoformans infections in AIDS patientsZentralbl Bakteriol Hyg266167177Google Scholar
  11. 11.
    Lehmann, PF, Lin, D,, Lasker, BA 1992Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNAJ Clin Microbiol3032493254PubMedGoogle Scholar
  12. 12.
    Meyer, W, Marszewska, K, Amirmostoflan, M, Pereira Igrja, R, Hardtke, C, Methling, K, Viviani, MA, Chindam, A, Sukroon-greund, S, John, MA, Ellis, D,, Sorrell, TC 1999Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA – A pilot study to standardize techniques on wich to base a detailed epidemiological surveyElectrophoresis2017901799CrossRefPubMedGoogle Scholar
  13. 13.
    National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Approved Standard M27-A2. 2nd ed. NCCLS, Wayne, PA. 2002Google Scholar
  14. 14.
    Nguyen, MH,, Yu, CY 1998In vitro comparative efficacy of Voriconazole and itraconazole againts Fluconazole-susceptible and -resistant Cryptococcus neoformans isolatesAntimicrob Agents Chemother42471472PubMedGoogle Scholar
  15. 15.
    Colom, MF, Alberdi, M, Meseguer, M,, Torres-Rodríguez, JM 1997Aislamiento de Cryptococcus neoformans en muestras de medio ambiente de AlicanteRev Iberoamer Micol146364Google Scholar
  16. 16.
    Garcia-Hermoso, D, Mathoulin-Pélissier, S, Couprie, B, Ronin, O, Dupont, B,, Dromer, F 1977DNA typing suggest pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype DJ Clin Microbiol3526832685Google Scholar
  17. 17.
    Swinne, D, Butzler, J, Claeys, G,  et al. 2000ECMM epidemiological survey on cryptococcosis in Europe: report from BelgiumRev Iberoam Micol17S145Google Scholar
  18. 18.
    Baró, T, Torres-Rodríguez, JM, Morera, Y, Alía, C, López, O,, Méndez, R 1999Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in SpainJ Clin Microbiol3711701172PubMedGoogle Scholar
  19. 19.
    Colom, MF, Frasés, S, Andreu, M, Ferrer, F, Jover, A,, Torres, JM 2003Primer caso autóctono de criptococosis humana por Cryptococcus neoformans variedad gattii en EspañaRev Iberoamer Micol20183Google Scholar
  20. 20.
    Guezuele, E, Calegari, L, Sanabria, D, Davel, G,, Civila, E 1993Isolation in Uruguay of Cryptococcus neoformans var. gattii from a nest of the wasp Polybia occidentalisRev Iberoam Micol1056Google Scholar
  21. 21.
    Bennett, JE, Kwon-Chung, KJ,, Howard, DH 1977Epidemiologic differences among serotypes of Cryptococcus neoformansAm J Epidemiol105582586PubMedGoogle Scholar
  22. 22.
    Baró, T, Torres-Rodríguez, JM, Alía, C, López, O,, Morera, Y 2001Relationship betgween in vitro activity of four antifungal drugs and the serotypes of Cryptococcus neoformansJ Mycol Méd11185190Google Scholar
  23. 23.
    Pfaller, MA, Zhang, J, Mecer, SA, Brandt, ME, Hajjeh, RA, Jessup, CJ, Tumberland, M, Mbidde, EK,, Ghannoum, MA 1999In vitro activities of Voriconazole, Fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and AfricaAntimicrob Agents Chemother43169171PubMedGoogle Scholar
  24. 24.
    Muñoz, P, Sainz, J, Rodríguez-Creixéms, , Santos, J, Alcalá, L,, Bouza, E 1999Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposoure to FluconazoleClin Infect Dis2915921593CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Yolanda Morera-López
    • 1
  • Josep Maria Torres-Rodríguez
    • 1
    • 2
  • Teresa Jiménez-Cabello
    • 1
  • Teresa Baró-Tomás
    • 1
    • 2
  • Concepción Alía-Aponte
    • 1
    • 2
  • Marcia S. Lázera
    • 3
  1. 1.Experimental and Clinical Mycology Research Unit (URMEC)Municipal Institute of Medical Research, IMAS, IMIMBarcelonaSpain
  2. 2.Universitat Autònoma de BarcelonaBarcelonaSpain
  3. 3.Mycology ServiceEvandro Chagas Institute of Clinical Research, IPEC/FIOCRUZRio de JaneiroBrasil

Personalised recommendations